Guangzhou Hexin Instrument Hits Day Low Amid Price Pressure, Shares at CNY 131.01

Guangzhou Hexin Instrument Co., Ltd. experienced significant volatility on February 24, 2026, with the stock declining by 11.27% and reaching an intraday low of CNY 131.01. This performance starkly contrasts with the China Shanghai Composite, which fell by only 1.26% on the same day. Despite a positive trajectory over the past month, where the stock gained 24.06%, the recent downturn highlights underlying financial concerns. The company has reported consecutive negative results in its last two quarters, with a pre-tax profit of CNY -22.89 million, reflecting a dramatic decline of 3,615.12%. Additionally, the net profit plummeted to CNY -18.74 million, marking a staggering drop of 20,339.17%. Guangzhou Hexin's long-term fundamentals appear weak, with net sales decreasing at an annual rate of 21.81% over the past five years. The company also carries a debt-to-equity ratio of 0.61, indicating a high level of debt relative to its equity. As a mid-cap player in the pharmaceuticals and biotechnology sector, these financial metrics suggest a challenging environment for the company moving forward.